Evidence map›Paper›PMID 38543874›Full record

ArticleVaccines2024

Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study.

Pere Godoy, Iván Martínez-Baz, Ignasi Parron, Manuel García-Cenoz, Joaquim Ferras, Mònica Carol, Nuria Bes, Montserrat Guillaumes, Sofia Godoy, Diana Toledo and 13 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Impact of Smoking on Household SARS-CoV-2 Transmission.Healthcare (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Pere GodoyInstitut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain.ORCID 0000-0002-2896-7286
Iván Martínez-BazCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-3405-2277
Ignasi ParronAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.ORCID 0000-0002-4875-0236
Manuel García-CenozCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-7316-9104
Joaquim FerrasAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Mònica CarolAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Nuria BesAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Montserrat GuillaumesAgència de Salut Pública de Barcelona, 08023 Barcelona, Spain.
Sofia GodoyInstitut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain.
Diana ToledoCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0003-0794-9238
Núria FolliaAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Carme MiretInstitut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain.ORCID 0000-0001-6154-3998
Jessica PardosAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.ORCID 0009-0005-8568-9605
Miquel AlsedàInstitut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain.
Pedro Plans-RubioCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-4424-2971
Inma SanzAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Maria-Rosa SalaAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.
Joan A CaylàBarcelona Tuberculosis Research Unit Foundation, 08008 Barcelona, Spain.ORCID 0000-0003-3891-111X
Jacobo MendiorozAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.ORCID 0000-0002-8883-2180
Carmen Muñoz-AlmagroCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-5586-404X
Jesús CastillaCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-6396-7265
Ángela DomínguezCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0003-0219-1907
On Behalf Of The Sars-CoV-Transmission To Household Contacts Working Group

Funding

Instituto de Salud Carlos III PI21/01883
6 · The paper itself

Abstract

The aim of this study was to evaluate the impact of index case vaccination on SARS-CoV-2 transmission to household contacts. In our epidemiological cohort study (May 2022-November 2023), we surveyed registered index case vaccination status and test results for contacts (testing on day 0, and on day 7 for negative contacts) and calculated the secondary attack rate (SAR), i.e., newly infected contacts/susceptible included contacts. The association of the independent variable, index case COVID-19 vaccination (yes/no), with household contact infection was determined using the adjusted odds ratio (aOR) and its 95% confidence interval (CI). We recorded 181 index cases and 314 contacts, of whom 250 agreed to participate; 16 contacts were excluded upon testing positive on day 0. Of the 234 included contacts, 49.1% were women, and the mean (SD) age was 51.9 (19.8) years. The overall SAR of 37.2% (87/234) was lower in the contacts of both vaccinated index cases (34.9% vs. 63.2%;

Indexed as

COVID-19household contactincidence rateSARS-CoV-2secondary attack ratevaccine

Identifiers

PMID38543874
PMCPMC10975059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.